Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
#f |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2/14/25 16:59 | 2/12/25 | RYTM | Health | Drug | Pharmaceutical Preparations | Smith Hunter C | MA | O | CFO | 5 | S.dm | -217 | 14.39 | 0 | -15 | 106 | D | |||||||||||||||
2/14/25 16:57 | 2/12/25 | RYTM | Health | Drug | Pharmaceutical Preparations | Shulman Joseph | MA | O | Chief Te | 5 | S.dm | -148 | 13.85 | 0 | -11 | 6 | D | |||||||||||||||
2/14/25 16:55 | 2/12/25 | RYTM | Health | Drug | Pharmaceutical Preparations | Lee Jennifer Kayden | MA | O | EVP,Head | 6 | S.dm | -778 | 28.91 | 0 | -27 | 5 | D | |||||||||||||||
2/11/25 21:45 | 2/9/25 | RYTM | Health | Drug | Pharmaceutical Preparations | Cramer Pamela J. | MA | O | CHRO | 4 | M.d | 94 | 14.24 | 0 | 7 | 64 | 17 | D | ||||||||||||||
2/11/25 21:45 | 2/11/25 | RYTM | Health | Drug | Pharmaceutical Preparations | Cramer Pamela J. | MA | O | CHRO | 4 | S.d | -94 | 14.24 | 0 | -7 | 17 | D | |||||||||||||||
2/4/25 21:25 | 2/1/25 | RYTM | Health | Drug | Pharmaceutical Preparations | Meeker David P | MA | DO | P,CEO | 2 | M.d | 254 | 13.82 | 0 | 18 | 11 | 190 | D | ||||||||||||||
2/4/25 21:25 | 2/4/25 | RYTM | Health | Drug | Pharmaceutical Preparations | Meeker David P | MA | DO | P,CEO | 2 | S.d | -254 | 13.82 | 0 | -18 | 190 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |